查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1500219

重组细胞培养补充品市场：按产品、来源、应用和最终用途 - 2024-2030 年全球预测

Recombinant Cell Culture Supplements Market by Product (Recombinant Albumin, Recombinant Aprotinin, Recombinant Growth Factors), Source (Animals, Human), Application, End-use - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

重组细胞培养补充品市场规模预计 2023 年为 6.8877 亿美元，2024 年达到 7.8431 亿美元，预计 2030 年将达到 17.6346 亿美元，复合年增长率为 14.37%。

重组细胞培养补充品是生物工程产品，旨在支持人工环境中细胞的生长、增殖和维持。这些补充品是透过重组 DNA 技术製造的，该技术将编码特定蛋白质或生长因子的 DNA 插入宿主细胞，从而产生这些所需的生物元件。其作用是优化成功培养哺乳动物、细菌和酵母细胞所需的细胞培养条件，以用于各种应用，包括治疗性蛋白质和疫苗的生产，以及在组织工程和再生医学中的应用。重组细胞培养补充品市场的主要驱动因素包括生物技术研究的进步、对生物製药的需求不断增长以及细胞培养方法在药物开发中的使用增加。此外，慢性病的全球流行正在推动新型疗法的市场开拓，进一步推动市场成长。儘管成长潜力巨大，重组细胞培养补充品市场仍面临挑战，特别是高製造成本和严格的监管要求。然而，再生医学和组织工程领域的不断扩大正在为重组细胞培养补充品市场创造重大机会。此外，干细胞治疗和基因工程研究的进步预计将为重组细胞培养补充品的应用开闢新途径，并成为市场扩张的驱动力。

主要市场统计
基准年[2023] 6.8877 亿美元
预测年份 [2024] 78431万美元
预测年份 [2030] 17.6346亿美元
复合年增长率（%） 14.37%

区域洞察

由于其先进的生物技术研究环境和对生命科学的大量投资，美洲地区在重组细胞培养补充品市场呈现出强劲的成长模式。特别是，对再生医学和细胞疗法的日益重视增加了对高品质重组补充品的需求。此外，该地区是主要生物製药公司和研究机构的所在地，提高了市场参与度和创新能力。 EMEA地区呈现多元化的市场表现，其特点是欧洲成长强劲，中东影响力逐渐增强，非洲稳步推进。欧洲市场受益于大量的研究资金、成熟的製药业以及支持生物技术创新的法规环境。同时，在生命科学战略投资的推动下，中东地区对生物製药研究的兴趣日益浓厚。儘管非洲在这一领域仍在发展，但由于对生物技术和医疗基础设施的认识和投资的增加，它显示出成长潜力。在中国、日本、韩国和印度等国家快速成长的生物技术产业的推动下，亚太地区预计将在重组细胞培养补充品市场中呈现最高的成长率。该地区受益于医疗基础设施的改善、生物製药研发投资的增加以及国内外生物技术公司的伙伴关係和合作的增加。

FPNV定位矩阵

FPNV 定位矩阵对于评估供应商在重组细胞培养补充品市场中的定位至关重要。此矩阵提供了对供应商的全面评估，并检验了与商务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果，供应商被分为代表其成功程度的四个像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可对重组细胞培养补充品市场供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献，您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他重要指标。此外，该分析还提供了对该行业竞争力的宝贵见解，包括在研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息，供应商可以做出更明智的决策并製定有效的策略，以在市场竞争中保持领先地位。

策略分析与建议

策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对重组细胞培养补充品市场当前地位的全面评估使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析，以确定核心优势和需要改进的领域。

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 肿瘤学和干细胞研究活动在全球扩展
      • 政府对生物相似药和生技药品的支持
    • 抑制因素
      • 重组细胞培养补充品相关的高成本
    • 机会
      • Novel Rise 介绍重组细胞培养补充品
      • 拓展3D细胞培养技术探索
    • 任务
      • 分析技术和 3D 细胞培养的不相容性
  • 市场区隔分析
    • 产品：扩大重组白蛋白在疫苗和治疗性蛋白质生产的用途
    • 最终用途：学术研究机构的持续研发活动将增加对重组细胞培养补充品的需求。
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章重组细胞培养补充品市场：副产品

  • 重组白蛋白
  • 重组抑肽酶
  • 重组生长因子
  • 重组胰岛素
  • 重组溶菌酶
  • 重组转铁蛋白
  • 重组胰蛋白酶

第七章重组细胞培养补充品市场：依来源分类

  • 动物
  • 人类

第八章重组细胞培养补充品市场：依应用分类

  • 基因治疗
  • 干细胞疗法
  • 疫苗开发

第九章重组细胞培养补充品市场：依最终用途

  • 学术研究所
  • 生物製药公司
  • 合约研究中心（CRO）

第十章美洲重组细胞培养补充品市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太重组细胞培养补充品市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲重组细胞培养补充品市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Core Biogenesis 和 Nucleus Biologics 宣布建立策略联盟，以实现具有成本永续的重组蛋白製造和分销
    • Albumedix 和 HeartSeed 宣布重组蛋白是 HeartSeed 的 HS-001 研究细胞疗法生产的关键辅料，该疗法开始了首次人体临床试验。
  • 战略分析和建议

第14章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-5C6F41F5B035

[188 Pages Report] The Recombinant Cell Culture Supplements Market size was estimated at USD 688.77 million in 2023 and expected to reach USD 784.31 million in 2024, at a CAGR 14.37% to reach USD 1,763.46 million by 2030.

Recombinant cell culture supplements are bioengineered products designed to support the growth, proliferation, and maintenance of cells in an artificial environment. These supplements are manufactured through recombinant DNA technology, which involves the insertion of DNA encoding specific proteins or growth factors into host cells, leading to the production of these desired biological elements. Their role is pivotal in optimizing the cell culture conditions necessary for the successful cultivation of mammalian, bacterial, or yeast cells for various applications, including the production of therapeutic proteins and vaccines and for use in tissue engineering and regenerative medicine. The primary drivers for the recombinant cell culture supplements market include advancements in biotechnology research, rising demand for biopharmaceuticals, and the increasing use of cell culture methods in drug development. Moreover, the rising prevalence of chronic diseases globally boosts the development of novel therapeutics, further propelling market growth. Despite the significant growth potential, the recombinant cell culture supplements market faces challenges, particularly in the form of high production costs and stringent regulatory requirements. However, the expanding field of regenerative medicine and tissue engineering presents considerable opportunities for the recombinant cell culture supplements market. Furthermore, the ongoing research in stem cell therapy and genetic engineering is expected to open new avenues for the application of recombinant cell culture supplements, thereby driving market expansion.

KEY MARKET STATISTICS
Base Year [2023] USD 688.77 million
Estimated Year [2024] USD 784.31 million
Forecast Year [2030] USD 1,763.46 million
CAGR (%) 14.37%

Regional Insights

The Americas region exhibits a robust growth pattern in the recombinant cell culture supplement market owing to its advanced biotechnological research landscape and substantial investments in life sciences. The growing emphasis on regenerative medicine and cell-based therapies particularly propels the demand for high-quality, recombinant supplements. Moreover, the presence of major biopharmaceutical companies and research institutions in this region amplifies market engagement and innovation. The EMEA region displays a diverse market performance characterized by strong growth in Europe, gradually increasing influence in the Middle East and steady advancements in Africa. The European market benefits from significant research funding, a well-established pharmaceutical industry, and a regulatory environment that supports biotechnological innovations. Meanwhile, the Middle East is witnessing an emerging interest in biopharmaceutical research, fuelled by strategic investments in life sciences. Africa, though still developing in this sector, shows potential for growth with increasing awareness and investment in biotechnology and healthcare infrastructure. Asia-Pacific is projected to exhibit the highest growth rate in the recombinant cell culture supplements market, driven by rapidly growing biotech sectors in countries such as China, Japan, South Korea, and India. The region benefits from improvements in healthcare infrastructure, rising investments in biopharmaceutical R&D, and an increasing number of partnerships and collaborations involving local and international biotech firms.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Recombinant Cell Culture Supplements Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Growing oncology and stem cell research activities globally
      • Supportive government initiatives for biosimilar and biologics products
    • Market Restraints
      • High cost associated with recombinant cell culture supplements
    • Market Opportunities
      • Rising introduction of novel recombinant cell culture supplements
      • Growing exploration of 3D cell culture technologies
    • Market Challenges
      • Incompatibilities of analytical technologies with 3D cell culture
  • Market Segmentation Analysis
    • Product: Increasing utilization of recombinant albumin for the production of vaccines and therapeutic proteins
    • End-use: Ongoing research & development activities academic and research institutes boosts the demand of recombinant cell culture supplements
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Recombinant Cell Culture Supplements Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Recombinant Cell Culture Supplements Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Core Biogenesis and Nucleus Biologics announce strategic collaboration for manufacturing and distribution of cost effective and sustainable recombinant proteins

Nucleus Biologics collaborates with Core Biogenesis to revolutionize the availability of Good Manufacturing Practice (GMP) recombinant proteins for the industry. This partnership designates Nucleus Biologics as the GMP manufacturer and distributor of Core Biogenesis' plant-expressed recombinant human proteins, integrating these advanced proteins into Krakatoa pod-based media manufacturing systems by Nucleus Biologics and Stoic Bio. [Published On: 2024-01-24]

Albumedix and Heartseed announce Recombumin as a critical excipient in the manufacture of Heartseed's HS-001 investigational cell therapy as its first in-human trial commences

Albumedix Ltd and Heartseed Inc. announced a pivotal development in cardiac therapy. Their collaboration has enabled the first human dosing of HS-001, an experimental treatment by Heartseed for advanced heart failure, utilizing Recombumin, a non-animal derived recombinant albumin, as an essential excipient. This partnership underscores Albumedix's commitment to enabling advanced therapeutic innovations, demonstrated by the strategic use of Recombumin to enhance cell viability and support cardiomyocyte sphere formation in HS-001. [Published On: 2023-03-14]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Recombinant Cell Culture Supplements Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Recombinant Cell Culture Supplements Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, Becton, Dickinson and Company, Bio-Techne Corporation, BPS Bioscience, Inc., Cell Sciences, Inc., Cytiva, F. Hoffmann-La Roche Ltd., FUJIFILM Corporation, HiMedia Laboratories Pvt Ltd, InVitria, Kerry Group PLC, Kingfisher Biotech, Inc., Laurus Labs Limited, Lonza Group Ltd., Merck KGaA, Novo Nordisk A/S, Novozymes A/S, PELOBIOTECH GmbH, Repligen Corporation, Sartorius AG, STEMCELL Technologies, Takara Bio Inc., Thermo Fisher Scientific Inc., and Zhuhai Gene-Biocon Biological Technology Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Recombinant Cell Culture Supplements Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Recombinant Albumin
    • Recombinant Aprotinin
    • Recombinant Growth Factors
    • Recombinant Insulin
    • Recombinant Lysozyme
    • Recombinant Transferrin
    • Recombinant Trypsin
  • Source
    • Animals
    • Human
  • Application
    • Gene Therapy
    • Stem Cell Therapy
    • Vaccine Development
  • End-use
    • Academic & Research Institutes
    • Biopharmaceutical Companies
    • Contract Research Centers (CROs)
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing oncology and stem cell research activities globally
      • 5.1.1.2. Supportive government initiatives for biosimilar and biologics products
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with recombinant cell culture supplements
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising introduction of novel recombinant cell culture supplements
      • 5.1.3.2. Growing exploration of 3D cell culture technologies
    • 5.1.4. Challenges
      • 5.1.4.1. Incompatibilities of analytical technologies with 3D cell culture
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Increasing utilization of recombinant albumin for the production of vaccines and therapeutic proteins
    • 5.2.2. End-use: Ongoing research & development activities academic and research institutes boosts the demand of recombinant cell culture supplements
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Recombinant Cell Culture Supplements Market, by Product

  • 6.1. Introduction
  • 6.2. Recombinant Albumin
  • 6.3. Recombinant Aprotinin
  • 6.4. Recombinant Growth Factors
  • 6.5. Recombinant Insulin
  • 6.6. Recombinant Lysozyme
  • 6.7. Recombinant Transferrin
  • 6.8. Recombinant Trypsin

7. Recombinant Cell Culture Supplements Market, by Source

  • 7.1. Introduction
  • 7.2. Animals
  • 7.3. Human

8. Recombinant Cell Culture Supplements Market, by Application

  • 8.1. Introduction
  • 8.2. Gene Therapy
  • 8.3. Stem Cell Therapy
  • 8.4. Vaccine Development

9. Recombinant Cell Culture Supplements Market, by End-use

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Biopharmaceutical Companies
  • 9.4. Contract Research Centers (CROs)

10. Americas Recombinant Cell Culture Supplements Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Recombinant Cell Culture Supplements Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Recombinant Cell Culture Supplements Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Core Biogenesis and Nucleus Biologics announce strategic collaboration for manufacturing and distribution of cost effective and sustainable recombinant proteins
    • 13.3.2. Albumedix and Heartseed announce Recombumin as a critical excipient in the manufacture of Heartseed's HS-001 investigational cell therapy as its first in-human trial commences
  • 13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET RESEARCH PROCESS
  • FIGURE 2. RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET DYNAMICS
  • FIGURE 7. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY RECOMBINANT ALBUMIN, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY RECOMBINANT ALBUMIN, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY RECOMBINANT APROTININ, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY RECOMBINANT APROTININ, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY RECOMBINANT GROWTH FACTORS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY RECOMBINANT GROWTH FACTORS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY RECOMBINANT INSULIN, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY RECOMBINANT INSULIN, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY RECOMBINANT LYSOZYME, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY RECOMBINANT LYSOZYME, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY RECOMBINANT TRANSFERRIN, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY RECOMBINANT TRANSFERRIN, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY RECOMBINANT TRYPSIN, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY RECOMBINANT TRYPSIN, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY ANIMALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY ANIMALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY HUMAN, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY HUMAN, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY GENE THERAPY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY STEM CELL THERAPY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY STEM CELL THERAPY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY CONTRACT RESEARCH CENTERS (CROS), BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY CONTRACT RESEARCH CENTERS (CROS), BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. AMERICAS RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 46. AMERICAS RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 47. AMERICAS RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 48. AMERICAS RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 49. AMERICAS RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 50. AMERICAS RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 51. AMERICAS RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 52. AMERICAS RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 53. AMERICAS RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 54. AMERICAS RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 55. ARGENTINA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 56. ARGENTINA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 57. ARGENTINA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 58. ARGENTINA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 59. ARGENTINA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 60. ARGENTINA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 61. ARGENTINA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 62. ARGENTINA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 63. BRAZIL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 64. BRAZIL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 65. BRAZIL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 66. BRAZIL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 67. BRAZIL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 68. BRAZIL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 69. BRAZIL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 70. BRAZIL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 71. CANADA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 72. CANADA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 73. CANADA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 74. CANADA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 75. CANADA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 76. CANADA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 77. CANADA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 78. CANADA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 79. MEXICO RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 80. MEXICO RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 81. MEXICO RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 82. MEXICO RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 83. MEXICO RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 84. MEXICO RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 85. MEXICO RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 86. MEXICO RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 87. UNITED STATES RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 88. UNITED STATES RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 89. UNITED STATES RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 90. UNITED STATES RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 91. UNITED STATES RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 92. UNITED STATES RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 93. UNITED STATES RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 94. UNITED STATES RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 95. UNITED STATES RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 96. UNITED STATES RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 107. AUSTRALIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 108. AUSTRALIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 109. AUSTRALIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 110. AUSTRALIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 111. AUSTRALIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 112. AUSTRALIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 113. AUSTRALIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 114. AUSTRALIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 115. CHINA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 116. CHINA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 117. CHINA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 118. CHINA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 119. CHINA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 120. CHINA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 121. CHINA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 122. CHINA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 123. INDIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 124. INDIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 125. INDIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 126. INDIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 127. INDIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 128. INDIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 129. INDIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 130. INDIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 131. INDONESIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 132. INDONESIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 133. INDONESIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 134. INDONESIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 135. INDONESIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 136. INDONESIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 137. INDONESIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 138. INDONESIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 139. JAPAN RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 140. JAPAN RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 141. JAPAN RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 142. JAPAN RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 143. JAPAN RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 144. JAPAN RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 145. JAPAN RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 146. JAPAN RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 147. MALAYSIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 148. MALAYSIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 149. MALAYSIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 150. MALAYSIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 151. MALAYSIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 152. MALAYSIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 153. MALAYSIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 154. MALAYSIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 155. PHILIPPINES RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 156. PHILIPPINES RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 157. PHILIPPINES RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 158. PHILIPPINES RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 159. PHILIPPINES RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 160. PHILIPPINES RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 161. PHILIPPINES RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 162. PHILIPPINES RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 163. SINGAPORE RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 164. SINGAPORE RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 165. SINGAPORE RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 166. SINGAPORE RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 167. SINGAPORE RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 168. SINGAPORE RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 169. SINGAPORE RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 170. SINGAPORE RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 171. SOUTH KOREA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 172. SOUTH KOREA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 173. SOUTH KOREA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 174. SOUTH KOREA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 175. SOUTH KOREA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 176. SOUTH KOREA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 177. SOUTH KOREA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 178. SOUTH KOREA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 179. TAIWAN RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 180. TAIWAN RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 181. TAIWAN RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 182. TAIWAN RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 183. TAIWAN RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 184. TAIWAN RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 185. TAIWAN RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 186. TAIWAN RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 187. THAILAND RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 188. THAILAND RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 189. THAILAND RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 190. THAILAND RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 191. THAILAND RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 192. THAILAND RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 193. THAILAND RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 194. THAILAND RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 195. VIETNAM RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 196. VIETNAM RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 197. VIETNAM RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 198. VIETNAM RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 199. VIETNAM RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 200. VIETNAM RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 201. VIETNAM RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 202. VIETNAM RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 213. DENMARK RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 214. DENMARK RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 215. DENMARK RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 216. DENMARK RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 217. DENMARK RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 218. DENMARK RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 219. DENMARK RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 220. DENMARK RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 221. EGYPT RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 222. EGYPT RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 223. EGYPT RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 224. EGYPT RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 225. EGYPT RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 226. EGYPT RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 227. EGYPT RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 228. EGYPT RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 229. FINLAND RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 230. FINLAND RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 231. FINLAND RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 232. FINLAND RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 233. FINLAND RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 234. FINLAND RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 235. FINLAND RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 236. FINLAND RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 237. FRANCE RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 238. FRANCE RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 239. FRANCE RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 240. FRANCE RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 241. FRANCE RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 242. FRANCE RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 243. FRANCE RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 244. FRANCE RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 245. GERMANY RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 246. GERMANY RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 247. GERMANY RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 248. GERMANY RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 249. GERMANY RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 250. GERMANY RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 251. GERMANY RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 252. GERMANY RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 253. ISRAEL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 254. ISRAEL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 255. ISRAEL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 256. ISRAEL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 257. ISRAEL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 258. ISRAEL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 259. ISRAEL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 260. ISRAEL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 261. ITALY RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 262. ITALY RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 263. ITALY RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 264. ITALY RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 265. ITALY RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 266. ITALY RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 267. ITALY RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 268. ITALY RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 269. NETHERLANDS RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 270. NETHERLANDS RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 271. NETHERLANDS RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 272. NETHERLANDS RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 273. NETHERLANDS RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 274. NETHERLANDS RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 275. NETHERLANDS RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 276. NETHERLANDS RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 277. NIGERIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 278. NIGERIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 279. NIGERIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 280. NIGERIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 281. NIGERIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 282. NIGERIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 283. NIGERIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 284. NIGERIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 285. NORWAY RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 286. NORWAY RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 287. NORWAY RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 288. NORWAY RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 289. NORWAY RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 290. NORWAY RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 291. NORWAY RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 292. NORWAY RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 293. POLAND RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 294. POLAND RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 295. POLAND RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 296. POLAND RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 297. POLAND RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 298. POLAND RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 299. POLAND RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 300. POLAND RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 301. QATAR RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 302. QATAR RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 303. QATAR RECOMBINANT CELL CULTURE SUPPL